Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Need some traders or chart guys on that one. Is this accumulation or black box?
Go ahead, shorty, make my day.
Looks like they made a good call just ahead of it.
To the moon!!!
Agreed that shorts have good reason to be cautious. There's a very good chance of getting left in the dust. My original post was poorly worded. What I actually was referring to was no morning reversal period with MMs dropping the bid to cover their shorts.
CP, what do you think about the SP holding through the morning MM shorting period?
Hmm...somebody wants in. Big time.
Looks like somebody wants some shares. <EOM>
It's all in the financing now. If there is non-dilutive financing, SP takes off. If BOD/mgmt used fast track news to take performance pressure off themselves by selling into the news with an ATM, then there is nothing to see here for a long time. All imo, of course.
Price follows volume. EOM.
How about $1.45 on 1.8 million shares?
Wook,
If she runs, $75 is a reasonable target. The question is whether she ever runs again. And even if not, a transient spike to the $5 range is not out of the question. All IMHO, of course.
Price follows volume.
I'll settle for four million.
Inflation could bring $10+ if you wait long enough.
CP, Agreed. I believe the last big price movement had as much to do with the bank financing announcement as the trial results. If there is a similar reason for the market to believe that there will be no more dilution, the PPS takes off.
Can't seem to find anyplace to buy the Nov 2014 555 calls!!! They must be putting them aside for the privileged few.
I think the concern would be unquantified financial exposure. This could also be a concern for a bank.
So is the current status dismissed without prejudice and a drop dead date of January 22 to amend the complaint?
A valid concern. I also wonder if they Abbvie may have told management to make the CA suit go away before they get on-board.
Sorry...I meant the clinical trial, not the BS court case.
The question that I have is now that the trial appears to be back on track where is Abbvie and where is the bank financing?
Four decimal place trades. Here we go again.
Who's got Level III? I bet all those large blocks today came pouring in from ShareBuilder.
Wook..
A quick move to $70 from here would not be unprecedented, without or without a tangible "catalyst" There is a LOT of volatility in small biotechs, and sometimes the price defies reason on the low and high side..all imho, of course.
Wook...at one time, the market thought the company was worth $70/share. Most or important or not, I'll settle for that valuation. ;)
Wook...I appreciate what you're suggesting, but could it also be possible that it's just hedge funds and market makers jerking with the share price because it's easy to jerk with the share price of basically any clinical stage biotech?
Okay, but how do "they" know they are taking "retail" shares off the street? What if "they" are just buying ATM shares? (which would contradict their alleged purpose by increasing the company's cash position.) Or what if the shares they are buying are MM inventory or MM shorts to fill orders? How many "retail" investors are going to dump their shares over a dime or a quarter price movement?
Okay, but who are "they?" Retail shares are being transferred to whom?
So does that mean that all previous references to partnering have been merely lip service?
Aren't most of the shares retail?
$70 was the high in March of 2000. I believe you are forgetting to adjust for the split.
An interesting theory, but can't the current PPS also be attributed to the relatively anemic volume recently?
Out of steam, and they're walking it down.
Deja vu all over again.
Okay...so PPHM was close to a partner before the dose switching debacle. But where is the partner now? If Abbive was interested then, they should have a line of big pharma suitors now that the FDA design approval is in hand. What is scaring potential partners away?
Definitely intriguing. But the other question is how many shares were just traded back and forth by black box algos?
If they can scare some longs out. But it looks like most of the long positions are dug in.
Certainly unusual. But wouldn't you need a negative catalyst to break down at this point? It looks like the longs are holding fast.